Evidence map›Paper›PMID 42205745›Full record

ArticleFrontiers in oncology2026

A CT-based multi-scale fusion model with SHAP interpretation for preoperative differentiation between lung adenocarcinoma in situ/minimally invasive adenocarcinoma and invasive adenocarcinoma: a multicenter study.

Ning Dong, Shihang Sun, Zhongwei Li, Zhenjie Cong, Yi Lin, Jingxian Chen, Hu Zhang, Yuxin Liu, Shuxia Li, Jing Xu and 2 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ning Dong *Department of Radiology, Yantaishan Hospital, Yantai, China.
Shihang Sun *Department of Medical Imaging, Weifang Yidu Central Hospital, Qingzhou, China.
Zhongwei LiDepartment of Radiology, Yantaishan Hospital, Yantai, China.
Zhenjie CongDepartment of Radiology, Yantaishan Hospital, Yantai, China.
Yi LinDepartment of Radiology, Yantaishan Hospital, Yantai, China.
Jingxian ChenDepartment of Radiology, Yantaishan Hospital, Yantai, China.
Hu ZhangDepartment of Radiology, Affiliated Hospital of Binzhou Medical University, Binzhou, China.
Yuxin LiuDepartment of Radiology, Yantaishan Hospital, Yantai, China.
Shuxia LiDepartment of Radiology, Yantaishan Hospital, Yantai, China.
Jing XuDepartment of Radiology, Yantaishan Hospital, Yantai, China.
Demin KongDepartment of Radiology, Zibo Central Hospital, Zibo, China.
Qingfeng YinDepartment of Radiology, Yantaishan Hospital, Yantai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To develop a multi-scale model integrating radiomics, habitat, deep learning, and clinical information for preoperative precise differentiation between lung adenocarcinoma in situ/minimally invasive adenocarcinoma and invasive adenocarcinoma in ground-glass nodules (GGNs). Methods: A total of 621 patients with GGNs from two centers were retrospectively enrolled. Radiomics, habitat, deep learning (2D, 2.5D, and 3D), and clinic models were constructed separately. Early fusion (feature-level fusion) and late fusion (decision-level fusion) strategies were systematically compared. The SHapley Additive exPlanations method was applied for interpretability analysis of the optimal model. Results: The early fusion model demonstrated superior performance, achieving areas under the receiver operating characteristic curves of 0.988, 0.903, and 0.872 in the training, internal validation, and external testing cohorts, respectively. Among the deep learning architectures, the 2.5D ResNet50 achieved the best performance. Conclusions: This multi-scale early fusion model provides robust support for preoperative precise diagnosis and individualized treatment decision-making for GGNs.

Indexed as

Deep learningground-glass noduleshabitatlung adenocarcinomaSHAP

Identifiers

PMID42205745
PMCPMC13201193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.